Skip to content

OBX — Obsidian Therapeutics Inc Institutional Holders · Q3 2026

Who owns Obsidian Therapeutics Inc (OBX)? 59 institutions reported holding $710.04M in SEC 13F filings for Q3 2026 (period ended 2026-09-30). Largest holders: Ra Capital Management, L.P. ($81.8M), Atlas Venture Life Science Advisors, LLC ($61.8M), Paradigm Biocapital Advisors LP ($57.1M).

RankInstitutionValueSharesChange
1RA CAPITAL MANAGEMENT, L.P.$81.8M6.0MNew
2Atlas Venture Life Science Advisors, LLC$61.8M4.5MNew
3Paradigm Biocapital Advisors LP$57.1M4.2MNew
4NOVO HOLDINGS A/S$42.9M3.1MNew
5VANGUARD GROUP INC$37.8M2.7MNew
6Trails Edge Capital Partners, LP$34.3M2.5MNew
7Octagon Capital Advisors LP$33.2M2.4MNew
8TCG Crossover Management, LLC$30.2M2.2MNew
9Deep Track Capital, LP$29.1M2.1MNew
10CITADEL ADVISORS LLC$26.7M1.9MNew
11Blue Owl Capital Holdings LP$20.4M1.5MNew
12Spruce Street Capital LP$17.2M1.2MNew
13Alphabet Inc.$16.8M1.2MNew
14Nantahala Capital Management, LLC$16.5M1.2MNew
15Logos Global Management LP$14.6M1.1MNew
16PRICE T ROWE ASSOCIATES INC /MD/$14.5M1.1MNew
17Nan Fung Group Holdings Ltd$12.6M918,765New
18Foresite Capital Management VI LLC$12.6M916,063New
19Caligan Partners LP$12.2M886,281New
20Pivotal bioVenture Partners Investment Advisor LLC$11.8M860,343New
21SAMSARA BIOCAPITAL, LLC$11.5M837,173New
22Redmile Group, LLC$11.4M833,157New
23BlackRock, Inc.$10.7M775,759New
24JANUS HENDERSON GROUP PLC$10.0M728,700New
25EVENTIDE ASSET MANAGEMENT, LLC$9.1M624,972New

Source: SEC Form 13F filings · as of 2026-09-30